Nanosys Inc. today announced that it has signed two agreements with Harvard University to combine their extensive intellectual property (IP) assets to facilitate out-licensing in two areas: nanowire-based biosensors and nanowire-based non-volatile memories. The IP is available for out-licensing to any interested third parties. The technologies being made available originate from the laboratory of Dr. Charles Lieber (Mark Hymen Professor of Chemistry at Harvard University), as well as many other nanotech researchers at Nanosys and other universities associated with Nanosys. The IP on offer includes Nanosys' extensive portfolio covering all aspects of nanowire production, functionalization, material interface technologies, fabrication technologies, basic devices using nanostructures, applications and architectures, and Harvard's portfolio of nanowire-based biosensor and non-volatile memory related IP.
"The agreements between Nanosys and Harvard reflect an innovative strategy to facilitate the development of two novel disruptive technologies," said Isaac T. Kohlberg, Harvard University's Senior Associate Provost and Chief Technology Development Officer. "We're delighted to be working in concert with Nanosys, a recognized leader in the nanowire space, to identify companies interested in acquiring rights to our innovative nanowire technologies for next-generation biosensors and non-volatile memory."
Andrew Filler, General Counsel and Vice-President of Intellectual Property at Nanosys, commented: "As companies are now realizing the significant commercial value of nanotechnology to expand upon and open up new markets, our goal is to help these companies address these markets using our intellectual property portfolio." He added, "After developing many fundamental technology platforms at Nanosys over the last several years, the company is now focused on commercializing technologies in core business areas including solid state lighting, electronics, energy storage and medical device applications. Our nanotechnology licensing program complements our core business focus, thereby providing the market with a convenient licensing option to our fundamental patent portfolio in areas that we are not fully exploiting ourselves."